Inventors:
Steven Shapiro - Boston MA, US
William Hartzell - Westborough MA, US
International Classification:
A61K038/46, C12N009/64
US Classification:
424/094650, 435/226000, 514/006000
Abstract:
The invention involves administration of MMPAP-12 polypeptides and nucleic acids for the treatment or prevention of infectious disease associated with microorganisms in subjects. The invention also relates to kits and compositions relating to the MMPAP-12 molecules.